Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New collagen mesh could reduce hernia surgery risks

NCT ID NCT07360691

Disease control Sponsor: Adichunchanagiri Institute of Medical Sciences, B G Nagara Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a special collagen mesh for hernia repair in 30 patients who were at high risk for complications, such as those with diabetes or infections. The mesh is designed to be absorbed by the body and help tissue heal naturally, avoiding problems linked to permanent synthetic mesh. Researchers tracked safety and wound healing for 8 weeks after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
High-Purity Type I Collagen Mesh (Surgicoll-Mesh®)
What this could lead to
If successful, this collagen mesh could offer a safer option for hernia repair in patients at high risk of complications, reducing infection and other issues.
What could go wrong
This is a small, early study with only 30 participants and no comparison group. The mesh is resorbable and may not provide long-term strength, and results may not apply to all hernia types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jan 2026

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Ventral, incisional, umbilical, or para-umbilical hernia * Contaminated or potentially contaminated surgical field * Hernia repair following infected mesh explantation * High-risk patients (diabetes, obesity, smoking, immunosuppression) * Ability to provide informed consent Exclusion Criteria: * Clean, low-risk primary hernia suitable for synthetic mesh * Large defects requiring permanent load-bearing prosthesis * Generalized peritonitis or uncontrolled sepsis * Known collagen hypersensitivity * Pregnancy * Inability to comply with follow-up

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal wall hernia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hernia Hernia, Abdominal Hernia, Inguinal Hernia, Ventral hiatus hernia Incisional Hernia Osteogenesis Imperfecta, Type IV Pain, Postoperative Postoperative Complications Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal wall hernia Hernia Incisional hernia İnguinal hernia Postoperative complications Surgical site infection Ventral hernia

Contacts and locations

Locations

  • Adichunchanagiri Institute of Medical Sciences

    Mandya, Karnataka, 571448, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.